Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000202590 | SCV000409974 | likely benign | Obesity | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000419291 | SCV000510930 | likely benign | not provided | 2016-12-02 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Personalized Diabetes Medicine Program, |
RCV000445524 | SCV000537107 | benign | Monogenic diabetes | 2019-01-25 | criteria provided, single submitter | research | ACMG criteria: BP4 (REVEL 0.138 + 7 predictors), BA1 (1.1% in gnomAD ENF), BS2 (142 cases and 120 controls in type2diabetesgenetics.org); susceptibility factor with conflicting data (protective and obesity susceptibility), called polymorphism in multiple publications=benign |
Genetic Services Laboratory, |
RCV000501342 | SCV000595714 | likely benign | not specified | 2017-05-12 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000419291 | SCV000842719 | benign | not provided | 2017-12-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000419291 | SCV001106702 | benign | not provided | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500636 | SCV002811825 | benign | BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 | 2021-08-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003977551 | SCV004798478 | benign | MC4R-related condition | 2019-07-08 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
UCL Genetics Institute, |
RCV000202590 | SCV000257525 | protective | Obesity | 2014-12-23 | no assertion criteria provided | case-control | |
Clinical Molecular Genetics Laboratory, |
RCV000202590 | SCV000692301 | uncertain significance | Obesity | 2012-06-22 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000501342 | SCV001918873 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000501342 | SCV001929009 | benign | not specified | no assertion criteria provided | clinical testing |